Why is HCAT down?
Down 4.6% today, more than its software peers' 1.3%; no story names it yet.
Fell 16% since Oct 28
Down 16% from Oct 28 to Nov 9 while the S&P 500 fell 3%.
- Its Nov 5 results:
Down 4.6% today, more than its software peers' 1.3%; no story names it yet.
Fell 16% since Oct 28
Down 16% from Oct 28 to Nov 9 while the S&P 500 fell 3%.
HCAT's Quality Score fell 2 points on Tue, Nov 10, to -8.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
| Holding it back | Moves 8.3% a day while sales shrink |
| Latest filing | 8-K, Nov 5 |
TodayNo story names it yet.
After its last 4 reports it closed -11.7% on average, higher 1 of 4 times.
Poorfor quality, not price, 1 of 14 chart checks firingWhat the Quality Score means
HCAT is #259 of 268 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 259 |
Expected to report Thu Mar 11, after the close (in 121 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $56.3M, 26% less than a year ago; a profit of $0.53 a share, from a loss of $0.32.
“The net income generated during the three months ended September 30, 2026 was largely driven by a $65.9 million gain on sale of the Vitalware Business, while total revenue, gross profit, gross margin, Adjusted Gross Profit, Adjusted Gross Margin, and Adjusted EBITDA decreased year-over-year primarily as a result of the divestiture of the Vitalware Business on July 31, 2026 and headwinds related to the migration from DOS to Ignite, partially offset by our cost reduction initiatives.”
HCAT's results filing gives no sales by line in a table we read.
| Measure | Figure |
|---|---|
| Total revenue | $246M to $249M |
Sales grew 11% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 12% a year over 5 years.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 5, 2026 | -2.7% | -2.7% | not yet |
| Aug 6, 2026 | -19.7% | -25.1% | -24.2% |
| May 11, 2026 | +5.8% | +7.3% | -8.0% |
Sales grew every year from 2018 to 2025, to $311M. It lost money in each of the eight years.
RSI 38.4, MACD below signal, below both averages. Not scored.
One insider bought $105K across 1 filing in the last 6 months. No open-market sales on record. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: HCAT is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
“We have experienced, and expect to continue to experience, intense competition from a number of companies.”
HCAT scores -8 today, which Breakaway calls Poor. It is #259 of 268 in Software by Quality Score, with 1 of 14 chart checks firing. Down 16% from Oct 28 to Nov 9 while the S&P 500 fell 3%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
HCAT scores -8 today, which Breakaway calls Poor (below zero). That is #259 of 268 in Software by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind HCAT's -8.
One insider bought $105K across 1 filing in the last 6 months. No open-market sales on record. The newest is Simeon Kohl, Chief Executive Officer, who bought $105K on Sep 14.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.